{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:22:31Z","timestamp":1788283351211,"version":"build-2803163510"},"reference-count":28,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Popular discourse often frames prescription stimulants Ritalin and Adderall as drugs for teens and emerging adults with greater financial resources (eg, students or young professionals), while illicit stimulants such as crack or methamphetamine are often considered drugs for older adults with lower incomes. Crack and methamphetamine are also frequently used in combination with opioids to offset the sedating effects of adulterants such as fentanyl and xylazine in the unregulated drug supply. This combination of stimulant and opioid use creates additional overdose risks and may require new public health approaches. Our team posited that creating effective messages to protect against overdose in the context of stimulant use entailed first developing a better understanding of which stimulants people are using in combination with opioids.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n While conducting formative research to develop a new intervention, our team sought to examine prescription stimulant use among participants, including middle-aged, lower-income, and homeless people. This entailed first ascertaining the prevalence of Ritalin and Adderall use among participants, and then asking people why they used them. We also sought to implement a novel AI-assisted coding methodology and to write up the steps we took as a replicable model that other research teams could readily use to facilitate their own data analysis.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We collected substance use screenings during 3 waves of data collection in 2025 (N=102 participants). In early 2026, we conducted 16 qualitative interviews with people who reported using Ritalin or Adderall. We then conducted mixed methods analyses to examine reported substance use, including the use of opioids and Ritalin or Adderall in combination, as well as potential relationships between using opioids with prescription stimulants and reporting a desire to stop using drugs. After conducting the interviews, we implemented a new hybrid methodology using AI tools to code interview transcripts and generate detailed reports accompanied by supporting quotes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Participants described using Ritalin or Adderall to manage negative effects of increasingly powerful opioids, including oversedation and withdrawal symptoms. A subset of participants who reported using both Ritalin or Adderall and opioids were 3.5 times more likely to agree or strongly agree with the statement \u201cI want to stop using drugs but I need help to do that\u201d compared to those who did not report using these substances in combination (19\/22, 86.4% vs 18\/28, 64.3%; odds ratio 3.52, 95% CI 0.83-14.89;\n P<\/jats:italic>\n =.09). Although not statistically significant, this difference may prove practically significant and merits further study.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The use of prescription stimulants appears to be increasingly common among new populations of people who use opioids, including those who report very low incomes and even homelessness. Additional research is warranted to examine how this type of polysubstance use may require different types of prevention strategies.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/99947","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:11:51Z","timestamp":1788282711000},"page":"e99947-e99947","source":"Crossref","is-referenced-by-count":0,"title":["Examining Increased Ritalin and Adderall Use Among Low-Income People Who Use Drugs: Mixed Methods Study"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-3810","authenticated-orcid":false,"given":"Ian David","family":"Aronson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5643-7665","authenticated-orcid":false,"given":"Robert","family":"Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4518-9181","authenticated-orcid":false,"given":"Anthony","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-5117","authenticated-orcid":false,"given":"Chunki","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-9925","authenticated-orcid":false,"given":"Alex S","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"32","key":"R1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.15585\/mmwr.mm7432a1","article-title":"Drug overdose deaths involving stimulants - United States, January 2018-June 2024","volume":"74","author":"Tanz","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","journal-title":"Curr Opin Psychiatry"},{"key":"R3","unstructured":"Stimulant use and stimulant use disorder in New York State. Office of Addiction Services and Supports. 2024. URL: https:\/\/oasas.ny.gov\/system\/files\/documents\/2024\/01\/addiction-data-bulletin-2024-02.pdf [Accessed 09-08-2026]"},{"key":"R4","unstructured":"Unintentional drug poisoning (overdose) deaths in New York City in 2024. NYC Health; 2025. URL: https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/epi\/databrief150-unintentional-drug-death-2025.pdf [Accessed 09-08-2026]"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104127","article-title":"Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA","volume":"119","author":"Paradise","journal-title":"Int J Drug Policy"},{"key":"R6","unstructured":"Aronson ID Cramer A Quiles R Bennett AS . Unpackaging why people who use drugs in New York City decline to connect with harm reduction services or obtain related resources (oral presentation). Presented at: AMERSA 49th Annual Conference 2025; Nov 13-15, 2025; Portland, OR."},{"issue":"5","key":"R7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/pcc.v02n0502","article-title":"Methylphenidate abuse and psychiatric side effects","volume":"2","author":"Morton","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"3","key":"R8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15374416.2024.2335625","article-title":"ADHD prevalence among U.S. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment","volume":"53","author":"Danielson","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10550887.2010.509273","article-title":"Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do","volume":"29","author":"Arria","journal-title":"J Addict Dis"},{"issue":"13","key":"R10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.15585\/mmwr.mm7213a1","article-title":"Trends in stimulant prescription fills among commercially insured children and adults - United States, 2016-2021","volume":"72","author":"Danielson","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115393","article-title":"Sociodemographic disparities in ADHD diagnosis and treatment among U.S. elementary school children","volume":"327","author":"Morgan","journal-title":"Psychiatry Res"},{"issue":"3","key":"R12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0407","article-title":"Racial and ethnic disparities in ADHD diagnosis and treatment","volume":"138","author":"Coker","journal-title":"Pediatrics"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14420","article-title":"Prevalence and correlates of prescription stimulant misuse among US college students: results from a national survey","volume":"84","author":"Wong","journal-title":"J Clin Psychiatry"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108297","article-title":"Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019","volume":"217","author":"Board","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"R15","doi-asserted-by":"publisher","first-page":"101265","DOI":"10.1016\/j.cppeds.2022.101265","article-title":"Stimulant misuse among youth","volume":"52","author":"LaBossier","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.2196\/59050","article-title":"ChatGPT for automated qualitative research: content analysis","volume":"26","author":"Bijker","journal-title":"J Med Internet Res"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.2196\/70122","article-title":"A practical guide and assessment on using ChatGPT to conduct grounded theory: tutorial","volume":"27","author":"Yue","journal-title":"J Med Internet Res"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1177\/16094069261426100","article-title":"Large language models in qualitative analysis: comparing traditional and researcher-interpreted approaches","volume":"25","author":"Misra","journal-title":"Int J Qual Methods"},{"key":"R19","unstructured":"The ASSIST project - Alcohol, Smoking and Substance Involvement Screening Test. World Health Organization. 2010. URL: https:\/\/www.who.int\/publications\/i\/item\/978924159938-2 [Accessed 09-08-2026]"},{"key":"R20","unstructured":"NIDA-modified Alcohol, Smoking, and Substance Involvement Screening Test. National Institutes of Health National Institute on Drug Abuse. URL: https:\/\/datashare.nida.nih.gov\/instrument\/nida-modified-alcohol-smoking-and-substance-involvement-screening-test [Accessed 09-08-2026]"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","DOI":"10.1111\/aphw.70038","article-title":"Generative AI for thematic analysis in a maternal health study: coding semistructured interviews using large language models","volume":"17","author":"Qiao","journal-title":"Appl Psychol Health Well Being"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1177\/16094069241231168","article-title":"An examination of the use of large language models to aid analysis of textual data","volume":"23","author":"Tai","journal-title":"Int J Qual Methods"},{"issue":"4","key":"R23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/10826084.2024.2434681","article-title":"Navigating the COVID-19 risk environment, overdose prevention, and self care practices of people who use illicit opioids in New York City","volume":"60","author":"Bennett","journal-title":"Subst Use Misuse"},{"issue":"2","key":"R24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","journal-title":"Int J Drug Policy"},{"issue":"3","key":"R25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","article-title":"Risk environments and drug harms: a social science for harm reduction approach","volume":"20","author":"Rhodes","journal-title":"Int J Drug Policy"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Aronson ID Bennett AS Marcus O Cramer AD Quiles R Fong C . Developing technology-based messaging to increase engagement with harm reduction services among people who use drugs in New York City. In: Proceedings of the 59th Hawaii International Conference on System Sciences. HICSS Conference Office; 2026:3959-3966. [doi: 10.24251\/HICSS.2026.472]","DOI":"10.24251\/HICSS.2026.472"},{"key":"R27","unstructured":"Aronson ID Cramer A Quiles R Fong C Bennett AS . New measures designed to assess relationships between substance use related attitudes, knowledge, and engagement with MAT [Poster]. Presented at: College on Problems of Drug Dependence (CPDD) Annual Meeting 2026; Jun 13-17, 2026; Portland, OR."},{"key":"R28","unstructured":"Together Against Overdose: community developed technology to encourage drug checking, distribution of harm reduction supplies, and linkage to services. HEAL Data Platform. URL: https:\/\/doi.org\/10.60490\/HDP01399 [Accessed 25-08-2026]"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:11:53Z","timestamp":1788282713000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e99947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2196\/99947","relation":{},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"v10i32e99947"}}